We see a world without blindness.

The pursuit of transformative, elegant, precise solutions to restore and preserve vision.

We are developing potential therapies for eye diseases using a proprietary treatment approach where pharmacological candidates have access to the back of the eye through suprachoroidal injection. This new treatment paradigm offers potentially meaningful therapeutic benefit to patients suffering from sight threatening diseases like uveitis, retinal vein occlusion (RVO), diabetic macular edema (DME) and wet age related macular degeneration (wet AMD).

Right drug, right place.

Investigating treatments for chronic blinding disease of the
eye - right where the disease presents. 


Our leadership team

Our board of directors

Clay B. Thorp
Clay B. Thorp

Let’s get the conversation going

Questions? We’d love to hear from you.